{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:28:52Z","timestamp":1787045332927,"version":"build-2736575974"},"reference-count":273,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06138-7","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:47:36Z","timestamp":1787042856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Neuroimmune Duality of CD4\u207a T Cells: Drivers of Damage and Repair in the Brain"],"prefix":"10.1007","volume":"63","author":[{"given":"Nishant","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince Ahad","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyamcho Tshering","family":"Bhutia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasreen","family":"Uppal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anureet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurkiran","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6757-8592","authenticated-orcid":false,"given":"Sukesh Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"6138_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci8090177","author":"R Hussain","year":"2018","unstructured":"Hussain R, Zubair H, Pursell S, Shahab M (2018) Neurodegenerative diseases: regenerative mechanisms and novel therapeutic approaches. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci8090177","journal-title":"Brain Sci"},{"key":"6138_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102483","volume":"101","author":"M Sharma","year":"2024","unstructured":"Sharma M, Pal P, Gupta SK (2024) Deciphering the role of miRNAs in Alzheimer\u2019s disease: predictive targeting and pathway modulation \u2013 a systematic review. Ageing Res Rev 101:102483. https:\/\/doi.org\/10.1016\/j.arr.2024.102483","journal-title":"Ageing Res Rev"},{"key":"6138_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 8:267. https:\/\/doi.org\/10.1038\/s41392-023-01486-5","journal-title":"Signal Transduct Target Ther"},{"key":"6138_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong J-S (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57\u201369. https:\/\/doi.org\/10.1038\/nrn2038","journal-title":"Nat Rev Neurosci"},{"key":"6138_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.839","volume":"11","author":"YT Dabi","year":"2023","unstructured":"Dabi YT, Ajagbe AO, Degechisa ST (2023) Toll-like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential. Immun Inflamm Dis 11:e839. https:\/\/doi.org\/10.1002\/iid3.839","journal-title":"Immun Inflamm Dis"},{"key":"6138_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/pin.12520","volume":"67","author":"RH Takahashi","year":"2017","unstructured":"Takahashi RH, Nagao T, Gouras GK (2017) Plaque formation and the intraneuronal accumulation of \u03b2-amyloid in Alzheimer\u2019s disease. Pathol Int 67:185\u2013193. https:\/\/doi.org\/10.1111\/pin.12520","journal-title":"Pathol Int"},{"key":"6138_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.148797","volume":"1829","author":"M Sharma","year":"2024","unstructured":"Sharma M, Pal P, Gupta SK (2024) The neurotransmitter puzzle of Alzheimer\u2019s: dissecting mechanisms and exploring therapeutic horizons. Brain Res 1829:148797. https:\/\/doi.org\/10.1016\/j.brainres.2024.148797","journal-title":"Brain Res"},{"key":"6138_CR8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/mds.24962","volume":"27","author":"M Poulopoulos","year":"2012","unstructured":"Poulopoulos M, Levy OA, Alcalay RN (2012) The neuropathology of genetic Parkinson\u2019s disease. Mov Disord 27:831\u2013842. https:\/\/doi.org\/10.1002\/mds.24962","journal-title":"Mov Disord"},{"key":"6138_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/14728222.2020.1738390","volume":"24","author":"E Abati","year":"2020","unstructured":"Abati E, Bresolin N, Comi G, Corti S (2020) Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS). Expert Opin Ther Targets 24:295\u2013310. https:\/\/doi.org\/10.1080\/14728222.2020.1738390","journal-title":"Expert Opin Ther Targets"},{"key":"6138_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/JAD-215171","volume":"85","author":"A Crestini","year":"2022","unstructured":"Crestini A, Santilli F, Martellucci S et al (2022) Prions and neurodegenerative diseases: a focus on Alzheimer\u2019s disease. J Alzheimers Dis 85:503\u2013518. https:\/\/doi.org\/10.3233\/JAD-215171","journal-title":"J Alzheimers Dis"},{"key":"6138_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2024.105685","volume":"161","author":"M Sharma","year":"2024","unstructured":"Sharma M, Tanwar AK, Purohit PK et al (2024) Regulatory roles of microRNAs in modulating mitochondrial dynamics, amyloid beta fibrillation, microglial activation, and cholinergic signaling: implications for Alzheimer\u2019s disease pathogenesis. Neurosci Biobehav Rev 161:105685. https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105685","journal-title":"Neurosci Biobehav Rev"},{"key":"6138_CR12","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","volume":"53","author":"Y Tang","year":"2016","unstructured":"Tang Y, Le W (2016) Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol 53:1181\u20131194. https:\/\/doi.org\/10.1007\/s12035-014-9070-5","journal-title":"Mol Neurobiol"},{"key":"6138_CR13","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41590-018-0212-1","volume":"19","author":"WM Song","year":"2018","unstructured":"Song WM, Colonna M (2018) The identity and function of microglia in neurodegeneration. Nat Immunol 19:1048\u20131058. https:\/\/doi.org\/10.1038\/s41590-018-0212-1","journal-title":"Nat Immunol"},{"key":"6138_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.4103\/NRR.NRR-D-23-01595","volume":"20","author":"M Gao","year":"2025","unstructured":"Gao M, Wang X, Su S et al (2025) Meningeal lymphatic vessel crosstalk with central nervous system immune cells in aging and neurodegenerative diseases. Neural Regen Res 20:763\u2013778. https:\/\/doi.org\/10.4103\/NRR.NRR-D-23-01595","journal-title":"Neural Regen Res"},{"key":"6138_CR15","doi-asserted-by":"publisher","unstructured":"Merino JJ, Rodr\u00edguez-Arellano JJ, Busquets X, et al (2026) The immune-chemokine axis in Alzheimer\u2019s disease: roles of adaptive immune system in neuroinflammation and disease progression. Biomolecules 16. https:\/\/doi.org\/10.3390\/biom16060855","DOI":"10.3390\/biom16060855"},{"key":"6138_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12974-014-0201-8","volume":"11","author":"H Gonz\u00e1lez","year":"2014","unstructured":"Gonz\u00e1lez H, Pacheco R (2014) T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases. J Neuroinflammation 11:201. https:\/\/doi.org\/10.1186\/s12974-014-0201-8","journal-title":"J Neuroinflammation"},{"key":"6138_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","volume":"28","author":"J Zhu","year":"2010","unstructured":"Zhu J, Yamane H, Paul WE (2010) Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 28:445\u2013489. https:\/\/doi.org\/10.1146\/annurev-immunol-030409-101212","journal-title":"Annu Rev Immunol"},{"key":"6138_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.872167","volume":"13","author":"W Liu","year":"2022","unstructured":"Liu W, Fan M, Lu W et al (2022) Emerging roles of T helper cells in non-infectious neuroinflammation: savior or sinner. Front Immunol 13:872167. https:\/\/doi.org\/10.3389\/fimmu.2022.872167","journal-title":"Front Immunol"},{"key":"6138_CR19","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.immuni.2012.09.007","volume":"37","author":"J Zhu","year":"2012","unstructured":"Zhu J, Jankovic D, Oler AJ et al (2012) The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. Immunity 37:660\u2013673. https:\/\/doi.org\/10.1016\/j.immuni.2012.09.007","journal-title":"Immunity"},{"key":"6138_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/382174a0","volume":"382","author":"MH Kaplan","year":"1996","unstructured":"Kaplan MH, Sun YL, Hoey T, Grusby MJ (1996) Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174\u2013177. https:\/\/doi.org\/10.1038\/382174a0","journal-title":"Nature"},{"key":"6138_CR21","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.4049\/jimmunol.173.6.3916","volume":"173","author":"JK Olson","year":"2004","unstructured":"Olson JK, Miller SD (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173:3916\u20133924. https:\/\/doi.org\/10.4049\/jimmunol.173.6.3916","journal-title":"J Immunol"},{"key":"6138_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ymeth.2026.01.002","volume":"247","author":"P Pal","year":"2026","unstructured":"Pal P, Sharma M, Gupta SK (2026) Navigating the frontier of human microglia isolation-standardization and translational insight. Methods 247:63\u201384. https:\/\/doi.org\/10.1016\/j.ymeth.2026.01.002","journal-title":"Methods"},{"key":"6138_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cells13090749","author":"Y Gao","year":"2024","unstructured":"Gao Y, Lu Y, Liang X et al (2024) CD4(+) T-cell senescence in neurodegenerative disease: pathogenesis and potential therapeutic targets. Cells. https:\/\/doi.org\/10.3390\/cells13090749","journal-title":"Cells"},{"key":"6138_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235\u2013238. https:\/\/doi.org\/10.1038\/nature04753","journal-title":"Nature"},{"key":"6138_CR25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm1651","volume":"13","author":"H Kebir","year":"2007","unstructured":"Kebir H, Kreymborg K, Ifergan I et al (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13:1173\u20131175. https:\/\/doi.org\/10.1038\/nm1651","journal-title":"Nat Med"},{"key":"6138_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/sj.cr.7310002","volume":"16","author":"J Zhu","year":"2006","unstructured":"Zhu J, Yamane H, Cote-Sierra J et al (2006) GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res 16:3\u201310. https:\/\/doi.org\/10.1038\/sj.cr.7310002","journal-title":"Cell Res"},{"key":"6138_CR27","doi-asserted-by":"publisher","first-page":"10714","DOI":"10.1523\/JNEUROSCI.1922-07.2007","volume":"27","author":"ED Ponomarev","year":"2007","unstructured":"Ponomarev ED, Maresz K, Tan Y, Dittel BN (2007) CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci Off J Soc Neurosci 27:10714\u201310721. https:\/\/doi.org\/10.1523\/JNEUROSCI.1922-07.2007","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"6138_CR28","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s41423-023-01043-8","volume":"20","author":"T Mamuladze","year":"2023","unstructured":"Mamuladze T, Kipnis J (2023) Type 2 immunity in the brain and brain borders. Cell Mol Immunol 20:1290\u20131299. https:\/\/doi.org\/10.1038\/s41423-023-01043-8","journal-title":"Cell Mol Immunol"},{"key":"6138_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330\u2013336. https:\/\/doi.org\/10.1038\/ni904","journal-title":"Nat Immunol"},{"key":"6138_CR30","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DAA Vignali","year":"2008","unstructured":"Vignali DAA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8:523\u2013532. https:\/\/doi.org\/10.1038\/nri2343","journal-title":"Nat Rev Immunol"},{"key":"6138_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fmolb.2020.00037","volume":"7","author":"J Jiao","year":"2020","unstructured":"Jiao J, Zhao G, Wang Y et al (2020) MCC950, a selective inhibitor of nlrp3 inflammasome, reduces the inflammatory response and improves neurological outcomes in mice model of spinal cord injury. Front Mol Biosci 7:37. https:\/\/doi.org\/10.3389\/fmolb.2020.00037","journal-title":"Front Mol Biosci"},{"key":"6138_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.609921","volume":"11","author":"DC Ivan","year":"2020","unstructured":"Ivan DC, Walthert S, Berve K et al (2020) Dwellers and trespassers: mononuclear phagocytes at the borders of the central nervous system. Front Immunol 11:609921. https:\/\/doi.org\/10.3389\/fimmu.2020.609921","journal-title":"Front Immunol"},{"key":"6138_CR33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s11481-019-09888-5","volume":"15","author":"Y Huang","year":"2020","unstructured":"Huang Y, Liu Z, Cao B-B et al (2020) Treg cells attenuate neuroinflammation and protect neurons in a mouse model of Parkinson\u2019s disease. J Neuroimmune Pharmacol 15:224\u2013237. https:\/\/doi.org\/10.1007\/s11481-019-09888-5","journal-title":"J Neuroimmune Pharmacol"},{"key":"6138_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00281-016-0604-y","volume":"39","author":"W Elyaman","year":"2017","unstructured":"Elyaman W, Khoury SJ (2017) Th9 cells in the pathogenesis of EAE and multiple sclerosis. Semin Immunopathol 39:79\u201387. https:\/\/doi.org\/10.1007\/s00281-016-0604-y","journal-title":"Semin Immunopathol"},{"key":"6138_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00382","author":"JL Quinn","year":"2018","unstructured":"Quinn JL, Kumar G, Agasing A et al (2018) Role of TFH cells in promoting T helper 17-induced neuroinflammation. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.00382","journal-title":"Front Immunol"},{"key":"6138_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.imlet.2014.10.011","volume":"162","author":"JMM den Haan","year":"2014","unstructured":"den Haan JMM, Arens R, van Zelm MC (2014) The activation of the adaptive immune system: cross-talk between antigen-presenting cells, T cells and B cells. Immunol Lett 162:103\u2013112. https:\/\/doi.org\/10.1016\/j.imlet.2014.10.011","journal-title":"Immunol Lett"},{"key":"6138_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/925135","volume":"2012","author":"RV Luckheeram","year":"2012","unstructured":"Luckheeram RV, Zhou R, Verma AD, Xia B (2012) CD4+T cells: differentiation and functions. Clin Dev Immunol 2012:925135. https:\/\/doi.org\/10.1155\/2012\/925135","journal-title":"Clin Dev Immunol"},{"key":"6138_CR38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun L, Su Y, Jiao A et al (2023) T cells in health and disease. Signal Transduct Target Ther 8:235. https:\/\/doi.org\/10.1038\/s41392-023-01471-y","journal-title":"Signal Transduct Target Ther"},{"key":"6138_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000369933","volume":"15","author":"M Fakhoury","year":"2015","unstructured":"Fakhoury M (2015) Role of immunity and inflammation in the pathophysiology of neurodegenerative diseases. Neurodegener Dis 15:63\u201369. https:\/\/doi.org\/10.1159\/000369933","journal-title":"Neurodegener Dis"},{"key":"6138_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01905","volume":"8","author":"STT Schetters","year":"2017","unstructured":"Schetters STT, Gomez-Nicola D, Garcia-Vallejo JJ, Van Kooyk Y (2017) Neuroinflammation: microglia and T cells get ready to tango. Front Immunol 8:1905. https:\/\/doi.org\/10.3389\/fimmu.2017.01905","journal-title":"Front Immunol"},{"key":"6138_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00375-7","volume":"15","author":"J Machhi","year":"2020","unstructured":"Machhi J, Kevadiya BD, Muhammad IK et al (2020) Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders. Mol Neurodegener 15:32. https:\/\/doi.org\/10.1186\/s13024-020-00375-7","journal-title":"Mol Neurodegener"},{"key":"6138_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12974-022-02605-9","volume":"19","author":"A DeMaio","year":"2022","unstructured":"DeMaio A, Mehrotra S, Sambamurti K, Husain S (2022) The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases. J Neuroinflammation 19:251. https:\/\/doi.org\/10.1186\/s12974-022-02605-9","journal-title":"J Neuroinflammation"},{"key":"6138_CR43","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L et al (2020) Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler J 26:1816\u20131821. https:\/\/doi.org\/10.1177\/1352458520970841","journal-title":"Mult Scler J"},{"key":"6138_CR44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41583-024-00823-z","volume":"25","author":"MS Woo","year":"2024","unstructured":"Woo MS, Engler JB, Friese MA (2024) The neuropathobiology of multiple sclerosis. Nat Rev Neurosci 25:493\u2013513. https:\/\/doi.org\/10.1038\/s41583-024-00823-z","journal-title":"Nat Rev Neurosci"},{"key":"6138_CR45","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejphar.2015.03.042","volume":"759","author":"C Procaccini","year":"2015","unstructured":"Procaccini C, De Rosa V, Pucino V et al (2015) Animal models of multiple sclerosis. Eur J Pharmacol 759:182\u2013191. https:\/\/doi.org\/10.1016\/j.ejphar.2015.03.042","journal-title":"Eur J Pharmacol"},{"key":"6138_CR46","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/7651_2014_88","volume":"1304","author":"RL Terry","year":"2016","unstructured":"Terry RL, Ifergan I, Miller SD (2016) Experimental autoimmune encephalomyelitis in mice. Methods Mol Biol 1304:145\u2013160. https:\/\/doi.org\/10.1007\/7651_2014_88","journal-title":"Methods Mol Biol"},{"key":"6138_CR47","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.autrev.2011.05.012","volume":"11","author":"C Kamm","year":"2012","unstructured":"Kamm C, Zettl UK (2012) Autoimmune disorders affecting both the central and peripheral nervous system. Autoimmun Rev 11:196\u2013202. https:\/\/doi.org\/10.1016\/j.autrev.2011.05.012","journal-title":"Autoimmun Rev"},{"key":"6138_CR48","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nri2550","volume":"9","author":"J Goverman","year":"2009","unstructured":"Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9:393\u2013407. https:\/\/doi.org\/10.1038\/nri2550","journal-title":"Nat Rev Immunol"},{"key":"6138_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115431","author":"LA Kasatkina","year":"2021","unstructured":"Kasatkina LA, Rittchen S, Sturm EM (2021) Neuroprotective and immunomodulatory action of the endocannabinoid system under neuroinflammation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22115431","journal-title":"Int J Mol Sci"},{"key":"6138_CR50","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s00109-006-0065-1","volume":"84","author":"B Becher","year":"2006","unstructured":"Becher B, Bechmann I, Greter M (2006) Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J Mol Med (Berl) 84:532\u2013543. https:\/\/doi.org\/10.1007\/s00109-006-0065-1","journal-title":"J Mol Med (Berl)"},{"key":"6138_CR51","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.it.2024.08.005","volume":"45","author":"VS Gogoleva","year":"2024","unstructured":"Gogoleva VS, Mundt S, De Feo D, Becher B (2024) Mononuclear phagocytes in autoimmune neuroinflammation. Trends Immunol 45:814\u2013823. https:\/\/doi.org\/10.1016\/j.it.2024.08.005","journal-title":"Trends Immunol"},{"key":"6138_CR52","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbi.2010.01.014","volume":"24","author":"AC Murphy","year":"2010","unstructured":"Murphy AC, Lalor SJ, Lynch MA, Mills KHG (2010) Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun 24:641\u2013651. https:\/\/doi.org\/10.1016\/j.bbi.2010.01.014","journal-title":"Brain Behav Immun"},{"key":"6138_CR53","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1600-065X.2008.00700.x","volume":"226","author":"L Lyakh","year":"2008","unstructured":"Lyakh L, Trinchieri G, Provezza L et al (2008) Regulation of interleukin-12\/interleukin-23 production and the T-helper 17 response in humans. Immunol Rev 226:112\u2013131. https:\/\/doi.org\/10.1111\/j.1600-065X.2008.00700.x","journal-title":"Immunol Rev"},{"key":"6138_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00014","volume":"7","author":"S Malik","year":"2016","unstructured":"Malik S, Want MY, Awasthi A (2016) The emerging roles of gamma\u2013delta T cells in tissue inflammation in experimental autoimmune encephalomyelitis. Front Immunol 7:10.3389\/fimmu.2016.00014","journal-title":"Front Immunol"},{"key":"6138_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.580304","volume":"11","author":"J Wo","year":"2020","unstructured":"Wo J, Zhang F, Li Z et al (2020) The role of gamma-delta T cells in diseases of the central nervous system. Front Immunol 11:10.3389\/fimmu.2020.580304","journal-title":"Front Immunol"},{"key":"6138_CR56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4103\/2319-4170.155590","volume":"38","author":"FC Kurschus","year":"2015","unstructured":"Kurschus FC (2015) T cell mediated pathogenesis in EAE: molecular mechanisms. Biomed J 38:183\u2013193. https:\/\/doi.org\/10.4103\/2319-4170.155590","journal-title":"Biomed J"},{"key":"6138_CR57","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3389\/fimmu.2015.00619","volume":"6","author":"S Sinha","year":"2015","unstructured":"Sinha S, Boyden AW, Itani FR et al (2015) CD8(+) T-cells as immune regulators of multiple sclerosis. Front Immunol 6:619. https:\/\/doi.org\/10.3389\/fimmu.2015.00619","journal-title":"Front Immunol"},{"key":"6138_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","volume":"162","author":"JM Fletcher","year":"2010","unstructured":"Fletcher JM, Lalor SJ, Sweeney CM et al (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162:1\u201311. https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04143.x","journal-title":"Clin Exp Immunol"},{"key":"6138_CR59","doi-asserted-by":"publisher","unstructured":"Rifa\u2019i M, Kawamoto Y, Nakashima I, Suzuki H (2004) Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 200:1123\u20131134. https:\/\/doi.org\/10.1084\/jem.20040395","DOI":"10.1084\/jem.20040395"},{"key":"6138_CR60","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a029025","author":"BJ Kaskow","year":"2018","unstructured":"Kaskow BJ, Baecher-Allan C (2018) Effector T cells in multiple sclerosis. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a029025","journal-title":"Cold Spring Harb Perspect Med"},{"key":"6138_CR61","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41582-019-0253-6","volume":"15","author":"Y Dong","year":"2019","unstructured":"Dong Y, Yong VW (2019) When encephalitogenic T cells collaborate with microglia in multiple sclerosis. Nat Rev Neurol 15:704\u2013717. https:\/\/doi.org\/10.1038\/s41582-019-0253-6","journal-title":"Nat Rev Neurol"},{"key":"6138_CR62","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1021\/acschemneuro.8b00220","volume":"10","author":"B Kumar","year":"2019","unstructured":"Kumar B, Dwivedi AR, Sarkar B et al (2019) 4,6-Diphenylpyrimidine derivatives as dual inhibitors of monoamine oxidase and acetylcholinesterase for the treatment of Alzheimer\u2019s disease. ACS Chem Neurosci 10:252\u2013265. https:\/\/doi.org\/10.1021\/acschemneuro.8b00220","journal-title":"ACS Chem Neurosci"},{"key":"6138_CR63","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejmech.2018.02.078","volume":"150","author":"D Kumar","year":"2018","unstructured":"Kumar D, Gupta SK, Ganeshpurkar A et al (2018) Development of piperazinediones as dual inhibitor for treatment of Alzheimer\u2019s disease. Eur J Med Chem 150:87\u2013101. https:\/\/doi.org\/10.1016\/j.ejmech.2018.02.078","journal-title":"Eur J Med Chem"},{"key":"6138_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2024.105761","volume":"177","author":"M Sharma","year":"2024","unstructured":"Sharma M, Pal P, Gupta SK (2024) Advances in Alzheimer\u2019s disease: a multifaceted review of potential therapies and diagnostic techniques for early detection. Neurochem Int 177:105761. https:\/\/doi.org\/10.1016\/j.neuint.2024.105761","journal-title":"Neurochem Int"},{"key":"6138_CR65","doi-asserted-by":"publisher","first-page":"626","DOI":"10.22270\/jddt.v9i3.2835","volume":"9","author":"K Yadav","year":"2019","unstructured":"Yadav K, Lou Diana MM, Bhutia GT, Owoalade SA (2019) Review on aetiology, diagnosis and treatment of Alzheimer\u2019s disease. J Drug Deliv Ther 9:626\u2013633. https:\/\/doi.org\/10.22270\/jddt.v9i3.2835","journal-title":"J Drug Deliv Ther"},{"key":"6138_CR66","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fonc.2013.00063","volume":"3","author":"MJ Dobrzanski","year":"2013","unstructured":"Dobrzanski MJ (2013) Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy. Front Oncol 3:63. https:\/\/doi.org\/10.3389\/fonc.2013.00063","journal-title":"Front Oncol"},{"key":"6138_CR67","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.4103\/NRR.NRR-D-25-00274","volume":"21","author":"Y Chen","year":"2026","unstructured":"Chen Y, Yin P, Chen Q et al (2026) Neurodegenerative diseases and immune system: from pathogenic mechanism to therapy. Neural Regen Res 21:3387\u20133410. https:\/\/doi.org\/10.4103\/NRR.NRR-D-25-00274","journal-title":"Neural Regen Res"},{"key":"6138_CR68","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/imcb.12301","volume":"98","author":"A Webers","year":"2020","unstructured":"Webers A, Heneka MT, Gleeson PA (2020) The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer\u2019s disease. Immunol Cell Biol 98:28\u201341. https:\/\/doi.org\/10.1111\/imcb.12301","journal-title":"Immunol Cell Biol"},{"key":"6138_CR69","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nri.2016.123","volume":"17","author":"B Becher","year":"2017","unstructured":"Becher B, Spath S, Goverman J (2017) Cytokine networks in neuroinflammation. Nat Rev Immunol 17:49\u201359. https:\/\/doi.org\/10.1038\/nri.2016.123","journal-title":"Nat Rev Immunol"},{"key":"6138_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.932152","volume":"13","author":"Y Shi","year":"2022","unstructured":"Shi Y, Wei B, Li L et al (2022) Th17 cells and inflammation in neurological disorders: possible mechanisms of action. Front Immunol 13:932152. https:\/\/doi.org\/10.3389\/fimmu.2022.932152","journal-title":"Front Immunol"},{"key":"6138_CR71","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41573-022-00390-x","volume":"21","author":"H-G Lee","year":"2022","unstructured":"Lee H-G, Wheeler MA, Quintana FJ (2022) Function and therapeutic value of astrocytes in neurological diseases. Nat Rev Drug Discov 21:339\u2013358. https:\/\/doi.org\/10.1038\/s41573-022-00390-x","journal-title":"Nat Rev Drug Discov"},{"key":"6138_CR72","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.4155\/fmc-2019-0106","volume":"11","author":"R Swetha","year":"2019","unstructured":"Swetha R, Kumar D, Gupta SK et al (2019) Multifunctional hybrid sulfonamides as novel therapeutic agents for Alzheimer\u2019s disease. Future Med Chem 11:3161\u20133178. https:\/\/doi.org\/10.4155\/fmc-2019-0106","journal-title":"Future Med Chem"},{"key":"6138_CR73","doi-asserted-by":"publisher","unstructured":"Fu H, Yang J, Zhang M (2026) Treg\u2013microglia crosstalk in Alzheimer\u2019s disease: stage-dependent dynamics, molecular mechanisms, and translational challenge. Front Aging Neurosci Volume 18: https:\/\/doi.org\/10.3389\/fnagi.2026.1838306","DOI":"10.3389\/fnagi.2026.1838306"},{"key":"6138_CR74","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fncel.2018.00114","volume":"12","author":"H Solleiro-Villavicencio","year":"2018","unstructured":"Solleiro-Villavicencio H, Rivas-Arancibia S (2018) Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4(+)T cells in neurodegenerative diseases. Front Cell Neurosci 12:114. https:\/\/doi.org\/10.3389\/fncel.2018.00114","journal-title":"Front Cell Neurosci"},{"key":"6138_CR75","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cns.13569","volume":"27","author":"X Huang","year":"2021","unstructured":"Huang X, Hussain B, Chang J (2021) Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms. CNS Neurosci Ther 27:36\u201347. https:\/\/doi.org\/10.1111\/cns.13569","journal-title":"CNS Neurosci Ther"},{"key":"6138_CR76","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1093\/brain\/awaf167","volume":"148","author":"C Rickenbach","year":"2025","unstructured":"Rickenbach C, Mallone A, H\u00e4usle L et al (2025) Altered T-cell reactivity in the early stages of Alzheimer\u2019s disease. Brain 148:3364\u20133378. https:\/\/doi.org\/10.1093\/brain\/awaf167","journal-title":"Brain"},{"key":"6138_CR77","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC et al (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22:657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6","journal-title":"Nat Rev Immunol"},{"key":"6138_CR78","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/apha.12476","volume":"216","author":"M Levite","year":"2016","unstructured":"Levite M (2016) Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases. Acta Physiol (Oxf) 216:42\u201389. https:\/\/doi.org\/10.1111\/apha.12476","journal-title":"Acta Physiol (Oxf)"},{"key":"6138_CR79","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12038-018-9744-7","volume":"43","author":"SK Gupta","year":"2018","unstructured":"Gupta SK, Mesharam MK, Krishnamurthy S (2018) Electromagnetic radiation 2450 MHz exposure causes cognition deficit with mitochondrial dysfunction and activation of intrinsic pathway of apoptosis in rats. J Biosci 43:263\u2013276. https:\/\/doi.org\/10.1007\/s12038-018-9744-7","journal-title":"J Biosci"},{"key":"6138_CR80","doi-asserted-by":"publisher","unstructured":"Pajares M, I Rojo A, Manda G, et al (2020) Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications. Cells 9. https:\/\/doi.org\/10.3390\/cells9071687","DOI":"10.3390\/cells9071687"},{"key":"6138_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2014.00031","volume":"2","author":"A Carbo","year":"2014","unstructured":"Carbo A, Hontecillas R, Andrew T et al (2014) Computational modeling of heterogeneity and function of CD4+ T cells. Front Cell Dev Biol 2:31. https:\/\/doi.org\/10.3389\/fcell.2014.00031","journal-title":"Front Cell Dev Biol"},{"key":"6138_CR82","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","volume":"16","author":"E-K Tan","year":"2020","unstructured":"Tan E-K, Chao Y-X, West A et al (2020) Parkinson disease and the immune system - associations, mechanisms and therapeutics. Nat Rev Neurol 16:303\u2013318. https:\/\/doi.org\/10.1038\/s41582-020-0344-4","journal-title":"Nat Rev Neurol"},{"key":"6138_CR83","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12974-025-03359-w","volume":"22","author":"E Furusawa-Nishii","year":"2025","unstructured":"Furusawa-Nishii E, Solongo B, Rai K et al (2025) \u03b1-Synuclein orchestrates Th17 responses as antigen and adjuvant in Parkinson\u2019s disease. J Neuroinflammation 22:38. https:\/\/doi.org\/10.1186\/s12974-025-03359-w","journal-title":"J Neuroinflammation"},{"key":"6138_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/cells12071012","author":"S Isik","year":"2023","unstructured":"Isik S, Yeman Kiyak B, Akbayir R et al (2023) Microglia mediated neuroinflammation in Parkinson\u2019s disease. Cells. https:\/\/doi.org\/10.3390\/cells12071012","journal-title":"Cells"},{"key":"6138_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1656422","volume":"16","author":"IX Lou","year":"2025","unstructured":"Lou IX, Zhou H, Wan H (2025) The critical role of Th17 cells and IL-17A in autoimmune and inflammation-associated neurological diseases: mechanisms and therapeutic perspectives. Front Immunol 16:1656422. https:\/\/doi.org\/10.3389\/fimmu.2025.1656422","journal-title":"Front Immunol"},{"key":"6138_CR86","doi-asserted-by":"publisher","unstructured":"Sharma M, Pal P, Gupta SK (2024) Microglial mediators in autoimmune Uveitis: Bridging neuroprotection and neurotoxicity. Int Immunopharmacol 136:112309. https:\/\/doi.org\/10.1016\/j.intimp.2024.112309","DOI":"10.1016\/j.intimp.2024.112309"},{"key":"6138_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2024.578433","author":"M Sharma","year":"2024","unstructured":"Sharma M, Pal P, Gupta SK et al (2024) Microglial-mediated immune mechanisms in autoimmune uveitis: elucidating pathogenic pathways and targeted therapeutics. J Neuroimmunol. https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578433","journal-title":"J Neuroimmunol"},{"key":"6138_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.736978","volume":"8","author":"E Srinivasan","year":"2021","unstructured":"Srinivasan E, Chandrasekhar G, Chandrasekar P et al (2021) Alpha-synuclein aggregation in Parkinson\u2019s disease. Front Med 8:736978. https:\/\/doi.org\/10.3389\/fmed.2021.736978","journal-title":"Front Med"},{"key":"6138_CR89","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G et al (2023) Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14:176. https:\/\/doi.org\/10.1038\/s41419-023-05672-9","journal-title":"Cell Death Dis"},{"key":"6138_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15626-w","volume":"11","author":"CS Lindestam Arlehamn","year":"2020","unstructured":"Lindestam Arlehamn CS, Dhanwani R, Pham J et al (2020) \u03b1-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease. Nat Commun 11:1875. https:\/\/doi.org\/10.1038\/s41467-020-15626-w","journal-title":"Nat Commun"},{"key":"6138_CR91","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00401-021-02268-5","volume":"141","author":"AS Harms","year":"2021","unstructured":"Harms AS, Ferreira SA, Romero-Ramos M (2021) Periphery and brain, innate and adaptive immunity in Parkinson\u2019s disease. Acta Neuropathol 141:527\u2013545. https:\/\/doi.org\/10.1007\/s00401-021-02268-5","journal-title":"Acta Neuropathol"},{"key":"6138_CR92","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/ejn.14290","volume":"49","author":"MG Tansey","year":"2019","unstructured":"Tansey MG, Romero-Ramos M (2019) Immune system responses in Parkinson\u2019s disease: early and dynamic. Eur J Neurosci 49:364\u2013383. https:\/\/doi.org\/10.1111\/ejn.14290","journal-title":"Eur J Neurosci"},{"key":"6138_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242316766","author":"D Cossu","year":"2023","unstructured":"Cossu D, Hatano T, Hattori N (2023) The role of immune dysfunction in Parkinson\u2019s disease development. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms242316766","journal-title":"Int J Mol Sci"},{"key":"6138_CR94","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1126\/science.aag2638","volume":"353","author":"J Kipnis","year":"2016","unstructured":"Kipnis J (2016) Multifaceted interactions between adaptive immunity and the central nervous system. Science 353:766\u2013771. https:\/\/doi.org\/10.1126\/science.aag2638","journal-title":"Science"},{"key":"6138_CR95","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cell.2020.12.040","volume":"184","author":"J Rustenhoven","year":"2021","unstructured":"Rustenhoven J, Drieu A, Mamuladze T et al (2021) Functional characterization of the dural sinuses as a neuroimmune interface. Cell 184:1000\u20131016.e27. https:\/\/doi.org\/10.1016\/j.cell.2020.12.040","journal-title":"Cell"},{"key":"6138_CR96","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ et al (2015) Structural and functional features of central nervous system lymphatic vessels. Nature 523:337\u2013341. https:\/\/doi.org\/10.1038\/nature14432","journal-title":"Nature"},{"key":"6138_CR97","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S1474-4422(18)30318-1","volume":"17","author":"MK Rasmussen","year":"2018","unstructured":"Rasmussen MK, Mestre H, Nedergaard M (2018) The glymphatic pathway in neurological disorders. Lancet Neurol 17:1016\u20131024. https:\/\/doi.org\/10.1016\/S1474-4422(18)30318-1","journal-title":"Lancet Neurol"},{"key":"6138_CR98","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nri.2016.144","volume":"17","author":"T Korn","year":"2017","unstructured":"Korn T, Kallies A (2017) T cell responses in the central nervous system. Nat Rev Immunol 17:179\u2013194. https:\/\/doi.org\/10.1038\/nri.2016.144","journal-title":"Nat Rev Immunol"},{"key":"6138_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2026.103042","volume":"116","author":"S Majumdar","year":"2026","unstructured":"Majumdar S, Samaiya PK, Gupta SK et al (2026) Aging and neuropathic pain: mitochondria-to-glia cascade, system mechanisms, and therapeutic strategies. Ageing Res Rev 116:103042. https:\/\/doi.org\/10.1016\/j.arr.2026.103042","journal-title":"Ageing Res Rev"},{"key":"6138_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218011","author":"X Zhu","year":"2020","unstructured":"Zhu X, Zhu J (2020) CD4 T helper cell subsets and related human immunological disorders. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21218011","journal-title":"Int J Mol Sci"},{"key":"6138_CR101","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrn.2017.39","volume":"18","author":"AJ Filiano","year":"2017","unstructured":"Filiano AJ, Gadani SP, Kipnis J (2017) How and why do T cells and their derived cytokines affect the injured and healthy brain? Nat Rev Neurosci 18:375\u2013384. https:\/\/doi.org\/10.1038\/nrn.2017.39","journal-title":"Nat Rev Neurosci"},{"key":"6138_CR102","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nri3152","volume":"12","author":"SL Swain","year":"2012","unstructured":"Swain SL, McKinstry KK, Strutt TM (2012) Expanding roles for CD4+ T cells in immunity to viruses. Nat Rev Immunol 12:136\u2013148. https:\/\/doi.org\/10.1038\/nri3152","journal-title":"Nat Rev Immunol"},{"key":"6138_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.703527","volume":"12","author":"A Ferro","year":"2021","unstructured":"Ferro A, Auguste YSS, Cheadle L (2021) Microglia, cytokines, and neural activity: unexpected interactions in brain development and function. Front Immunol 12:703527. https:\/\/doi.org\/10.3389\/fimmu.2021.703527","journal-title":"Front Immunol"},{"key":"6138_CR104","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s11904-019-00445-6","volume":"16","author":"C Subra","year":"2019","unstructured":"Subra C, Trautmann L (2019) Role of T lymphocytes in HIV neuropathogenesis. Curr HIV AIDS Rep 16:236\u2013243. https:\/\/doi.org\/10.1007\/s11904-019-00445-6","journal-title":"Curr HIV AIDS Rep"},{"key":"6138_CR105","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/QCO.0000000000000825","volume":"35","author":"TP Johnson","year":"2022","unstructured":"Johnson TP, Nath A (2022) Biotypes of HIV-associated neurocognitive disorders based on viral and immune pathogenesis. Curr Opin Infect Dis 35:223\u2013230. https:\/\/doi.org\/10.1097\/QCO.0000000000000825","journal-title":"Curr Opin Infect Dis"},{"key":"6138_CR106","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.it.2015.12.008","volume":"37","author":"E Ellwardt","year":"2016","unstructured":"Ellwardt E, Walsh JT, Kipnis J, Zipp F (2016) Understanding the role of T cells in CNS homeostasis. Trends Immunol 37:154\u2013165. https:\/\/doi.org\/10.1016\/j.it.2015.12.008","journal-title":"Trends Immunol"},{"key":"6138_CR107","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nri2189","volume":"7","author":"Y Belkaid","year":"2007","unstructured":"Belkaid Y (2007) Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 7:875\u2013888. https:\/\/doi.org\/10.1038\/nri2189","journal-title":"Nat Rev Immunol"},{"key":"6138_CR108","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.bbi.2007.11.010","volume":"22","author":"BN Dittel","year":"2008","unstructured":"Dittel BN (2008) CD4 T cells: balancing the coming and going of autoimmune-mediated inflammation in the CNS. Brain Behav Immun 22:421\u2013430. https:\/\/doi.org\/10.1016\/j.bbi.2007.11.010","journal-title":"Brain Behav Immun"},{"key":"6138_CR109","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11481-022-10056-5","volume":"17","author":"J Wang","year":"2022","unstructured":"Wang J, Nan Y, Liu M, Hu K (2022) The role of CD4(+) T cells in the immunotherapy of brain disease by secreting different cytokines. J Neuroimmune Pharmacol 17:409\u2013422. https:\/\/doi.org\/10.1007\/s11481-022-10056-5","journal-title":"J Neuroimmune Pharmacol"},{"key":"6138_CR110","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/imr.12066","volume":"254","author":"AA Okoye","year":"2013","unstructured":"Okoye AA, Picker LJ (2013) CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol Rev 254:54\u201364. https:\/\/doi.org\/10.1111\/imr.12066","journal-title":"Immunol Rev"},{"key":"6138_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00947","volume":"11","author":"J Milovanovic","year":"2020","unstructured":"Milovanovic J, Arsenijevic A, Stojanovic B et al (2020) Interleukin-17 in chronic inflammatory neurological diseases. Front Immunol 11:947. https:\/\/doi.org\/10.3389\/fimmu.2020.00947","journal-title":"Front Immunol"},{"key":"6138_CR112","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1212\/WNL.0000000000012781","volume":"97","author":"V Saini","year":"2021","unstructured":"Saini V, Guada L, Yavagal DR (2021) Global epidemiology of stroke and access to acute ischemic stroke interventions. Neurology 97:S6\u2013S16. https:\/\/doi.org\/10.1212\/WNL.0000000000012781","journal-title":"Neurology"},{"key":"6138_CR113","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1001\/jamaneurol.2020.3362","volume":"77","author":"F Akbik","year":"2020","unstructured":"Akbik F, Xu H, Xian Y et al (2020) Trends in reperfusion therapy for in-hospital ischemic stroke in the endovascular therapy era. JAMA Neurol 77:1486\u20131495. https:\/\/doi.org\/10.1001\/jamaneurol.2020.3362","journal-title":"JAMA Neurol"},{"key":"6138_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30078-X","author":"K Shi","year":"2019","unstructured":"Shi K, Tian D, Li Z et al (2019) Global brain inflammation in stroke. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(19)30078-X","journal-title":"Lancet Neurol"},{"key":"6138_CR115","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s42466-020-00060-6","volume":"2","author":"C Grefkes","year":"2020","unstructured":"Grefkes C, Fink GR (2020) Recovery from stroke: current concepts and future perspectives. Neurol Res Pract 2:17. https:\/\/doi.org\/10.1186\/s42466-020-00060-6","journal-title":"Neurol Res Pract"},{"key":"6138_CR116","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","volume":"20","author":"T Gong","year":"2020","unstructured":"Gong T, Liu L, Jiang W, Zhou R (2020) DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol 20:95\u2013112. https:\/\/doi.org\/10.1038\/s41577-019-0215-7","journal-title":"Nat Rev Immunol"},{"key":"6138_CR117","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1161\/CIRCRESAHA.121.319994","volume":"130","author":"M Endres","year":"2022","unstructured":"Endres M, Moro MA, Nolte CH et al (2022) Immune pathways in etiology, acute phase, and chronic sequelae of ischemic stroke. Circ Res 130:1167\u20131186. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.319994","journal-title":"Circ Res"},{"key":"6138_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1512634","volume":"16","author":"Z Lian","year":"2025","unstructured":"Lian Z, Luo Y, Li Y et al (2025) CD4(+) T cells in ischemic stroke: effects and therapeutic targets. Front Immunol 16:1512634. https:\/\/doi.org\/10.3389\/fimmu.2025.1512634","journal-title":"Front Immunol"},{"key":"6138_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00480","volume":"22","author":"DQ Ng","year":"2025","unstructured":"Ng DQ, Hudson C, Nguyen T et al (2025) Dynamin-1 is a potential mediator in cancer-related cognitive impairment. Neurother J Am Soc Exp Neurother 22:e00480. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00480","journal-title":"Neurother J Am Soc Exp Neurother"},{"key":"6138_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.707972","volume":"12","author":"D Zhang","year":"2021","unstructured":"Zhang D, Ren J, Luo Y et al (2021) T cell response in ischemic stroke: from mechanisms to translational insights. Front Immunol 12:707972. https:\/\/doi.org\/10.3389\/fimmu.2021.707972","journal-title":"Front Immunol"},{"key":"6138_CR121","doi-asserted-by":"publisher","DOI":"10.1177\/1756286418774254","volume":"11","author":"E G\u00fclke","year":"2018","unstructured":"G\u00fclke E, Gelderblom M, Magnus T (2018) Danger signals in stroke and their role on microglia activation after ischemia. Ther Adv Neurol Disord 11:1756286418774254. https:\/\/doi.org\/10.1177\/1756286418774254","journal-title":"Ther Adv Neurol Disord"},{"key":"6138_CR122","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-018-0824-5","volume":"565","author":"M Ito","year":"2019","unstructured":"Ito M, Komai K, Mise-Omata S et al (2019) Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery. Nature 565:246\u2013250. https:\/\/doi.org\/10.1038\/s41586-018-0824-5","journal-title":"Nature"},{"key":"6138_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00294","volume":"11","author":"S Xu","year":"2020","unstructured":"Xu S, Lu J, Shao A et al (2020) Glial cells: role of the immune response in ischemic stroke. Front Immunol 11:294. https:\/\/doi.org\/10.3389\/fimmu.2020.00294","journal-title":"Front Immunol"},{"key":"6138_CR124","doi-asserted-by":"publisher","DOI":"10.1177\/1756286418789854","volume":"11","author":"A Drieu","year":"2018","unstructured":"Drieu A, Levard D, Vivien D, Rubio M (2018) Anti-inflammatory treatments for stroke: from bench to bedside. Ther Adv Neurol Disord 11:1756286418789854. https:\/\/doi.org\/10.1177\/1756286418789854","journal-title":"Ther Adv Neurol Disord"},{"key":"6138_CR125","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1177\/23969873221098857","volume":"7","author":"AE Ben","year":"2022","unstructured":"Ben AE, Molad J, Seyman E et al (2022) Preventing post-stroke dementia. The MARCH Trial. Protocol and statistical analysis plan of a randomized clinical trial testing the safety and efficacy of Maraviroc in post-stroke cognitive impairment. Eur stroke J 7:314\u2013322. https:\/\/doi.org\/10.1177\/23969873221098857","journal-title":"Eur stroke J"},{"key":"6138_CR126","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.immuni.2010.08.013","volume":"33","author":"F Petermann","year":"2010","unstructured":"Petermann F, Rothhammer V, Claussen MC et al (2010) \u03b3\u03b4 T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity 33:351\u2013363. https:\/\/doi.org\/10.1016\/j.immuni.2010.08.013","journal-title":"Immunity"},{"key":"6138_CR127","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00134-022-06702-4","volume":"48","author":"G Meyfroidt","year":"2022","unstructured":"Meyfroidt G, Bouzat P, Casaer MP et al (2022) Management of moderate to severe traumatic brain injury: an update for the intensivist. Intensive Care Med 48:649\u2013666. https:\/\/doi.org\/10.1007\/s00134-022-06702-4","journal-title":"Intensive Care Med"},{"key":"6138_CR128","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1111\/nicc.12973","volume":"29","author":"R Shanahan","year":"2024","unstructured":"Shanahan R, Avsar P, Watson C et al (2024) The impact of brain tissue oxygenation monitoring on the Glasgow Outcome Scale\/Glasgow Outcome Scale Extended in patients with moderate to severe traumatic brain injury: a systematic review. Nurs Crit Care 29:1460\u20131469. https:\/\/doi.org\/10.1111\/nicc.12973","journal-title":"Nurs Crit Care"},{"key":"6138_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2019.04.001","volume":"128","author":"SK Gupta","year":"2019","unstructured":"Gupta SK, Patel SK, Tomar MS et al (2019) Long-term exposure of 2450\u202fMHz electromagnetic radiation induces stress and anxiety like behavior in rats. Neurochem Int 128:1\u201313. https:\/\/doi.org\/10.1016\/j.neuint.2019.04.001","journal-title":"Neurochem Int"},{"key":"6138_CR130","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s00221-024-06856-1","volume":"242","author":"BZ McDonald","year":"2024","unstructured":"McDonald BZ, Tarudji AW, Zhang H et al (2024) Traumatic brain injury heterogeneity affects cell death and autophagy. Exp Brain Res 242:1645\u20131658. https:\/\/doi.org\/10.1007\/s00221-024-06856-1","journal-title":"Exp Brain Res"},{"key":"6138_CR131","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13104-017-2459-2","volume":"10","author":"V Albert","year":"2017","unstructured":"Albert V, Subramanian A, Agrawal D et al (2017) RANTES levels in peripheral blood, CSF and contused brain tissue as a marker for outcome in traumatic brain injury (TBI) patients. BMC Res Notes 10:139. https:\/\/doi.org\/10.1186\/s13104-017-2459-2","journal-title":"BMC Res Notes"},{"key":"6138_CR132","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70580","volume":"31","author":"MD Kilgore","year":"2025","unstructured":"Kilgore MD, Xiu Y, Jiang Y et al (2025) T cell involvement in neuroinflammation after traumatic brain injury: implications for therapeutic intervention. CNS Neurosci Ther 31:e70580. https:\/\/doi.org\/10.1111\/cns.70580","journal-title":"CNS Neurosci Ther"},{"key":"6138_CR133","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/brain\/awad304","volume":"147","author":"W Wen","year":"2024","unstructured":"Wen W, Cheng J, Tang Y (2024) Brain perivascular macrophages: current understanding and future prospects. Brain 147:39\u201355. https:\/\/doi.org\/10.1093\/brain\/awad304","journal-title":"Brain"},{"key":"6138_CR134","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.bbi.2010.10.017","volume":"25","author":"F Al Nimer","year":"2011","unstructured":"Al Nimer F, Beyeen AD, Lindblom R et al (2011) Both MHC and non-MHC genes regulate inflammation and T-cell response after traumatic brain injury. Brain Behav Immun 25:981\u2013990. https:\/\/doi.org\/10.1016\/j.bbi.2010.10.017","journal-title":"Brain Behav Immun"},{"key":"6138_CR135","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/s1286-4579(02)00050-3","volume":"5","author":"Y Yang","year":"2003","unstructured":"Yang Y (2003) Generation of major histocompatibility complex class I antigens. Microbes Infect 5:39\u201347. https:\/\/doi.org\/10.1016\/s1286-4579(02)00050-3","journal-title":"Microbes Infect"},{"key":"6138_CR136","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038661","author":"SJ Turner","year":"2021","unstructured":"Turner SJ, Bennett TJ, La Gruta NL (2021) CD8(+) T-cell memory: the why, the when, and the how. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a038661","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"6138_CR137","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fimmu.2017.00292","volume":"8","author":"M Wieczorek","year":"2017","unstructured":"Wieczorek M, Abualrous ET, Sticht J et al (2017) Major histocompatibility complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation. Front Immunol 8:292. https:\/\/doi.org\/10.3389\/fimmu.2017.00292","journal-title":"Front Immunol"},{"key":"6138_CR138","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq0712","volume":"9","author":"SX Shi","year":"2023","unstructured":"Shi SX, Xiu Y, Li Y et al (2023) CD4(+) T cells aggravate hemorrhagic brain injury. Sci Adv 9:eabq0712. https:\/\/doi.org\/10.1126\/sciadv.abq0712","journal-title":"Sci Adv"},{"key":"6138_CR139","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.4049\/jimmunol.159.12.5956","volume":"159","author":"X Tao","year":"1997","unstructured":"Tao X, Constant S, Jorritsma P, Bottomly K (1997) Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation. J Immunol 159:5956\u20135963","journal-title":"J Immunol"},{"key":"6138_CR140","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11910-024-01382-7","volume":"24","author":"E C\u00e1ceres","year":"2024","unstructured":"C\u00e1ceres E, Olivella JC, Di Napoli M et al (2024) Immune response in traumatic brain injury. Curr Neurol Neurosci Rep 24:593\u2013609. https:\/\/doi.org\/10.1007\/s11910-024-01382-7","journal-title":"Curr Neurol Neurosci Rep"},{"key":"6138_CR141","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1097\/JS9.0000000000002420","volume":"111","author":"J-Y Zhao","year":"2025","unstructured":"Zhao J-Y, Zhou Y, Zhou C-W et al (2025) Revisiting the critical roles of reactive microglia in traumatic brain injury. Int J Surg 111:3942\u20133978. https:\/\/doi.org\/10.1097\/JS9.0000000000002420","journal-title":"Int J Surg"},{"key":"6138_CR142","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13092","volume":"54","author":"L Xu","year":"2021","unstructured":"Xu L, Ye X, Wang Q et al (2021) T-cell infiltration, contribution and regulation in the central nervous system post-traumatic injury. Cell Prolif 54:e13092. https:\/\/doi.org\/10.1111\/cpr.13092","journal-title":"Cell Prolif"},{"key":"6138_CR143","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1097\/JS9.0000000000003689","volume":"112","author":"Q Zhao","year":"2026","unstructured":"Zhao Q, Chen B-A, Ai W-Q et al (2026) The immunological paradox of CD4+ T cells in traumatic brain injury. Int J Surg 112:4366\u20134386. https:\/\/doi.org\/10.1097\/JS9.0000000000003689","journal-title":"Int J Surg"},{"key":"6138_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.945063","volume":"13","author":"K Kokubo","year":"2022","unstructured":"Kokubo K, Onodera A, Kiuchi M et al (2022) Conventional and pathogenic Th2 cells in inflammation, tissue repair, and fibrosis. Front Immunol 13:945063. https:\/\/doi.org\/10.3389\/fimmu.2022.945063","journal-title":"Front Immunol"},{"key":"6138_CR145","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1550-0","volume":"16","author":"TJ Kr\u00e4mer","year":"2019","unstructured":"Kr\u00e4mer TJ, Hack N, Br\u00fchl TJ et al (2019) Depletion of regulatory T cells increases T cell brain infiltration, reactive astrogliosis, and interferon-\u03b3 gene expression in acute experimental traumatic brain injury. J Neuroinflammation 16:163. https:\/\/doi.org\/10.1186\/s12974-019-1550-0","journal-title":"J Neuroinflammation"},{"key":"6138_CR146","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","volume":"19","author":"M Dominguez-Villar","year":"2018","unstructured":"Dominguez-Villar M, Hafler DA (2018) Regulatory T cells in autoimmune disease. Nat Immunol 19:665\u2013673. https:\/\/doi.org\/10.1038\/s41590-018-0120-4","journal-title":"Nat Immunol"},{"key":"6138_CR147","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/nn.3469","volume":"16","author":"VE Miron","year":"2013","unstructured":"Miron VE, Boyd A, Zhao J-W et al (2013) M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 16:1211\u20131218. https:\/\/doi.org\/10.1038\/nn.3469","journal-title":"Nat Neurosci"},{"key":"6138_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpolymj.2024.113457","volume":"220","author":"P Pal","year":"2024","unstructured":"Pal P, Sharma M, Singh Bani K, Kumar Gupta S (2024) Advances in neuronal regeneration: hydrogel-based delivery systems loaded with extracellular vesicles in modulating neural impulses and tissue repair. Eur Polym J 220:113457. https:\/\/doi.org\/10.1016\/j.eurpolymj.2024.113457","journal-title":"Eur Polym J"},{"key":"6138_CR149","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300752R","volume":"37","author":"X Qu","year":"2023","unstructured":"Qu X, Hou X, Zhu K et al (2023) Neutrophil extracellular traps facilitate sympathetic hyperactivity by polarizing microglia toward M1 phenotype after traumatic brain injury. FASEB J 37:e23112. https:\/\/doi.org\/10.1096\/fj.202300752R","journal-title":"FASEB J"},{"key":"6138_CR150","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4049\/jimmunol.1900838","volume":"204","author":"Z Papadopoulos","year":"2020","unstructured":"Papadopoulos Z, Herz J, Kipnis J (2020) Meningeal lymphatics: from anatomy to central nervous system immune surveillance. J Immunol 204:286\u2013293. https:\/\/doi.org\/10.4049\/jimmunol.1900838","journal-title":"J Immunol"},{"key":"6138_CR151","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.20142290","volume":"212","author":"A Aspelund","year":"2015","unstructured":"Aspelund A, Antila S, Proulx ST et al (2015) A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med 212:991\u2013999. https:\/\/doi.org\/10.1084\/jem.20142290","journal-title":"J Exp Med"},{"key":"6138_CR152","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00538","volume":"8","author":"T Cronin","year":"2017","unstructured":"Cronin T, Arshad Q, Seemungal BM (2017) Vestibular deficits in neurodegenerative disorders: balance, dizziness, and spatial disorientation. Front Neurol 8:538. https:\/\/doi.org\/10.3389\/fneur.2017.00538","journal-title":"Front Neurol"},{"key":"6138_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2024.100661","volume":"31","author":"B Dai","year":"2024","unstructured":"Dai B, Li T, Cao J et al (2024) CD4(+) T-cell subsets are associated with chronic stress effects in newly diagnosed anxiety disorders. Neurobiol Stress 31:100661. https:\/\/doi.org\/10.1016\/j.ynstr.2024.100661","journal-title":"Neurobiol Stress"},{"key":"6138_CR154","doi-asserted-by":"publisher","unstructured":"Guo J, Wang J, Liang P, et al (2024) Vestibular dysfunction leads to cognitive impairments: State\u00a0of\u00a0knowledge in the field and clinical perspectives (Review). Int J Mol Med 53. https:\/\/doi.org\/10.3892\/ijmm.2024.5360","DOI":"10.3892\/ijmm.2024.5360"},{"key":"6138_CR155","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10787-020-00712-8","volume":"28","author":"MO Welcome","year":"2020","unstructured":"Welcome MO (2020) Cellular mechanisms and molecular signaling pathways in stress-induced anxiety, depression, and blood-brain barrier inflammation and leakage. Inflammopharmacology 28:643\u2013665. https:\/\/doi.org\/10.1007\/s10787-020-00712-8","journal-title":"Inflammopharmacology"},{"key":"6138_CR156","unstructured":"Aghayan SK, Shabani AH, Badri T, Hosseni Nejad J, Esmaeili Gouvrchin Ghaleh H (2024) Relationship between stress and the immune system-related disorders. Int J Med Rev 11:775\u2013785"},{"key":"6138_CR157","doi-asserted-by":"publisher","first-page":"A271","DOI":"10.1016\/j.autrev.2009.11.014","volume":"9","author":"L Stojanovich","year":"2010","unstructured":"Stojanovich L (2010) Stress and autoimmunity. Autoimmun Rev 9:A271\u20136. https:\/\/doi.org\/10.1016\/j.autrev.2009.11.014","journal-title":"Autoimmun Rev"},{"key":"6138_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150778","volume":"734","author":"P Pal","year":"2024","unstructured":"Pal P, Sharma M, Gupta SK et al (2024) MiRNA-124 loaded extracellular vesicles encapsulated within hydrogel matrices for combating chemotherapy-induced neurodegeneration. Biochem Biophys Res Commun 734:150778. https:\/\/doi.org\/10.1016\/j.bbrc.2024.150778","journal-title":"Biochem Biophys Res Commun"},{"key":"6138_CR159","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.it.2009.04.003","volume":"30","author":"HE Lynch","year":"2009","unstructured":"Lynch HE, Goldberg GL, Chidgey A et al (2009) Thymic involution and immune reconstitution. Trends Immunol 30:366\u2013373. https:\/\/doi.org\/10.1016\/j.it.2009.04.003","journal-title":"Trends Immunol"},{"key":"6138_CR160","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/intimm\/dxaa006","volume":"32","author":"N Minato","year":"2020","unstructured":"Minato N, Hattori M, Hamazaki Y (2020) Physiology and pathology of T-cell aging. Int Immunol 32:223\u2013231. https:\/\/doi.org\/10.1093\/intimm\/dxaa006","journal-title":"Int Immunol"},{"key":"6138_CR161","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-020-0173-8","volume":"17","author":"R Thomas","year":"2020","unstructured":"Thomas R, Wang W, Su D-M (2020) Contributions of age-related thymic involution to immunosenescence and inflammaging. Immun Ageing 17:2. https:\/\/doi.org\/10.1186\/s12979-020-0173-8","journal-title":"Immun Ageing"},{"key":"6138_CR162","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1172\/JCI18104","volume":"112","author":"A Monsonego","year":"2003","unstructured":"Monsonego A, Zota V, Karni A et al (2003) Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. J Clin Invest 112:415\u2013422. https:\/\/doi.org\/10.1172\/JCI18104","journal-title":"J Clin Invest"},{"key":"6138_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102893","volume":"20","author":"M Dema","year":"2021","unstructured":"Dema M, Eixarch H, Villar LM et al (2021) Immunosenescence in multiple sclerosis: the identification of new therapeutic targets. Autoimmun Rev 20:102893. https:\/\/doi.org\/10.1016\/j.autrev.2021.102893","journal-title":"Autoimmun Rev"},{"key":"6138_CR164","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41582-019-0183-3","volume":"15","author":"CB Vaughn","year":"2019","unstructured":"Vaughn CB, Jakimovski D, Kavak KS et al (2019) Epidemiology and treatment of multiple sclerosis in elderly populations. Nat Rev Neurol 15:329\u2013342. https:\/\/doi.org\/10.1038\/s41582-019-0183-3","journal-title":"Nat Rev Neurol"},{"key":"6138_CR165","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.624380","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, Wang X, Lei L et al (2020) Age-related gene alteration in na\u00efve and memory T cells using precise age-tracking model. Front Cell Dev Biol 8:624380. https:\/\/doi.org\/10.3389\/fcell.2020.624380","journal-title":"Front Cell Dev Biol"},{"key":"6138_CR166","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41590-021-00927-z","volume":"22","author":"M Mittelbrunn","year":"2021","unstructured":"Mittelbrunn M, Kroemer G (2021) Hallmarks of T cell aging. Nat Immunol 22:687\u2013698. https:\/\/doi.org\/10.1038\/s41590-021-00927-z","journal-title":"Nat Immunol"},{"key":"6138_CR167","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13511","volume":"20","author":"L Dai","year":"2021","unstructured":"Dai L, Shen Y (2021) Insights into T-cell dysfunction in Alzheimer\u2019s disease. Aging Cell 20:e13511. https:\/\/doi.org\/10.1111\/acel.13511","journal-title":"Aging Cell"},{"key":"6138_CR168","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1007\/s00415-022-11190-z","volume":"269","author":"Y He","year":"2022","unstructured":"He Y, Peng K, Li R et al (2022) Changes of T lymphocyte subpopulations and their roles in predicting the risk of Parkinson\u2019s disease. J Neurol 269:5368\u20135381. https:\/\/doi.org\/10.1007\/s00415-022-11190-z","journal-title":"J Neurol"},{"key":"6138_CR169","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.it.2009.03.013","volume":"30","author":"N-P Weng","year":"2009","unstructured":"Weng N-P, Akbar AN, Goronzy J (2009) CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol 30:306\u2013312. https:\/\/doi.org\/10.1016\/j.it.2009.03.013","journal-title":"Trends Immunol"},{"key":"6138_CR170","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jaut.2011.11.006","volume":"38","author":"B Broux","year":"2012","unstructured":"Broux B, Pannemans K, Zhang X et al (2012) CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients. J Autoimmun 38:10\u201319. https:\/\/doi.org\/10.1016\/j.jaut.2011.11.006","journal-title":"J Autoimmun"},{"key":"6138_CR171","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.2174\/138161213805219711","volume":"19","author":"JP Chou","year":"2013","unstructured":"Chou JP, Effros RB (2013) T cell replicative senescence in human aging. Curr Pharm Des 19:1680\u20131698. https:\/\/doi.org\/10.2174\/138161213805219711","journal-title":"Curr Pharm Des"},{"key":"6138_CR172","doi-asserted-by":"publisher","unstructured":"Elyahu Y, Hekselman I, Eizenberg-Magar I, et al (2019) Aging promotes reorganization of the CD4 T cell landscape toward extreme regulatory and effector phenotypes. Sci Adv 5:eaaw8330. https:\/\/doi.org\/10.1126\/sciadv.aaw8330","DOI":"10.1126\/sciadv.aaw8330"},{"key":"6138_CR173","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.bbi.2010.12.004","volume":"25","author":"M Saresella","year":"2011","unstructured":"Saresella M, Calabrese E, Marventano I et al (2011) Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer\u2019s disease. Brain Behav Immun 25:539\u2013547. https:\/\/doi.org\/10.1016\/j.bbi.2010.12.004","journal-title":"Brain Behav Immun"},{"key":"6138_CR174","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12929-025-01146-6","volume":"32","author":"L Rousseau","year":"2025","unstructured":"Rousseau L, Hajdu KL, Ho P-C (2025) Meta-epigenetic shifts in T cell aging and aging-related dysfunction. J Biomed Sci 32:51. https:\/\/doi.org\/10.1186\/s12929-025-01146-6","journal-title":"J Biomed Sci"},{"key":"6138_CR175","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s11357-025-02062-1","volume":"48","author":"PA Mir","year":"2026","unstructured":"Mir PA, Kumar N, Bhutia GT et al (2026) The aging gut-glia-immune axis in Alzheimer\u2019s disease: microbiome-derived mediators of neuroinflammation and therapeutic innovation. GeroScience 48:2201\u20132241. https:\/\/doi.org\/10.1007\/s11357-025-02062-1","journal-title":"GeroScience"},{"key":"6138_CR176","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni.2771","volume":"15","author":"CL Lucas","year":"2014","unstructured":"Lucas CL, Kuehn HS, Zhao F et al (2014) Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency. Nat Immunol 15:88\u201397. https:\/\/doi.org\/10.1038\/ni.2771","journal-title":"Nat Immunol"},{"key":"6138_CR177","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jneuroim.2016.01.014","volume":"292","author":"Y Sun","year":"2016","unstructured":"Sun Y, Tian T, Gao J et al (2016) Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice. J Neuroimmunol 292:58\u201367. https:\/\/doi.org\/10.1016\/j.jneuroim.2016.01.014","journal-title":"J Neuroimmunol"},{"key":"6138_CR178","doi-asserted-by":"publisher","first-page":"9234","DOI":"10.18632\/aging.102438","volume":"11","author":"A Bektas","year":"2019","unstructured":"Bektas A, Schurman SH, Gonzalez-Freire M et al (2019) Age-associated changes in human CD4(+) T cells point to mitochondrial dysfunction consequent to impaired autophagy. Aging (Albany NY) 11:9234\u20139263. https:\/\/doi.org\/10.18632\/aging.102438","journal-title":"Aging (Albany NY)"},{"key":"6138_CR179","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1126\/science.aax0860","volume":"368","author":"G Desd\u00edn-Mic\u00f3","year":"2020","unstructured":"Desd\u00edn-Mic\u00f3 G, Soto-Heredero G, Aranda JF et al (2020) T cells with dysfunctional mitochondria induce multimorbidity and premature senescence. Science 368:1371\u20131376. https:\/\/doi.org\/10.1126\/science.aax0860","journal-title":"Science"},{"key":"6138_CR180","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.autrev.2005.04.005","volume":"4","author":"R Bacchetta","year":"2005","unstructured":"Bacchetta R, Gregori S, Roncarolo M-G (2005) CD4+ regulatory T cells: mechanisms of induction and effector function. Autoimmun Rev 4:491\u2013496. https:\/\/doi.org\/10.1016\/j.autrev.2005.04.005","journal-title":"Autoimmun Rev"},{"key":"6138_CR181","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/327470","volume":"2015","author":"EA Ivanova","year":"2015","unstructured":"Ivanova EA, Orekhov AN (2015) T helper lymphocyte subsets and plasticity in autoimmunity and cancer: an overview. Biomed Res Int 2015:327470. https:\/\/doi.org\/10.1155\/2015\/327470","journal-title":"Biomed Res Int"},{"key":"6138_CR182","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fimmu.2019.00043","volume":"10","author":"M Romano","year":"2019","unstructured":"Romano M, Fanelli G, Albany CJ et al (2019) Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity. Front Immunol 10:43. https:\/\/doi.org\/10.3389\/fimmu.2019.00043","journal-title":"Front Immunol"},{"key":"6138_CR183","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nature22395","volume":"545","author":"M Sadelain","year":"2017","unstructured":"Sadelain M, Rivi\u00e8re I, Riddell S (2017) Therapeutic T cell engineering. Nature 545:423\u2013431. https:\/\/doi.org\/10.1038\/nature22395","journal-title":"Nature"},{"key":"6138_CR184","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02398-x","volume":"19","author":"X Gao","year":"2022","unstructured":"Gao X, Li W, Syed F et al (2022) PD-L1 signaling in reactive astrocytes counteracts neuroinflammation and ameliorates neuronal damage after traumatic brain injury. J Neuroinflammation 19:43. https:\/\/doi.org\/10.1186\/s12974-022-02398-x","journal-title":"J Neuroinflammation"},{"key":"6138_CR185","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad186","volume":"5","author":"R Zeiser","year":"2023","unstructured":"Zeiser R, Prinz M (2023) Immune checkpoint inhibitor induced neurocognitive deficits in patients. Brain Commun 5:fcad186. https:\/\/doi.org\/10.1093\/braincomms\/fcad186","journal-title":"Brain Commun"},{"key":"6138_CR186","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/jam.15174","volume":"132","author":"R Vig","year":"2022","unstructured":"Vig R, Bhadra F, Gupta SK et al (2022) Neuroprotective effects of quercetin produced by an endophytic fungus Nigrospora oryzae isolated from Tinospora cordifolia. J Appl Microbiol 132:365\u2013380. https:\/\/doi.org\/10.1111\/jam.15174","journal-title":"J Appl Microbiol"},{"key":"6138_CR187","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.877936","volume":"13","author":"S Manenti","year":"2022","unstructured":"Manenti S, Orrico M, Masciocchi S et al (2022) PD-1\/PD-L axis in neuroinflammation: new insights. Front Neurol 13:877936. https:\/\/doi.org\/10.3389\/fneur.2022.877936","journal-title":"Front Neurol"},{"key":"6138_CR188","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah3374","author":"X Mao","year":"2016","unstructured":"Mao X, Ou MT, Karuppagounder SS et al (2016) Pathological \u03b1-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science. https:\/\/doi.org\/10.1126\/science.aah3374","journal-title":"Science"},{"key":"6138_CR189","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1007\/s12035-024-04560-3","volume":"62","author":"X Yin","year":"2025","unstructured":"Yin X, Li G, Ji F et al (2025) Tim-3 deficiency ameliorates motor deficits and neuroinflammation in MPP+\/MPTP-induced Parkinson\u2019s disease models via the NF-\u03baB\/NLRP3 pathway. Mol Neurobiol 62:5566\u20135578. https:\/\/doi.org\/10.1007\/s12035-024-04560-3","journal-title":"Mol Neurobiol"},{"key":"6138_CR190","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115467","volume":"165","author":"K Lama","year":"2025","unstructured":"Lama K, Bhutia GT, Deka R et al (2025) From inflammation to intervention: exploring shared mechanisms and lifestyle strategies in diabetes mellitus and multiple sclerosis. Int Immunopharmacol 165:115467. https:\/\/doi.org\/10.1016\/j.intimp.2025.115467","journal-title":"Int Immunopharmacol"},{"key":"6138_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113398","volume":"143","author":"Y Mi","year":"2024","unstructured":"Mi Y, Dong J, Liu C et al (2024) Amelioration of experimental autoimmune encephalomyelitis by exogenous soluble PD-L1 is associated with restraining dendritic cell maturation and CCR7-mediated migration. Int Immunopharmacol 143:113398. https:\/\/doi.org\/10.1016\/j.intimp.2024.113398","journal-title":"Int Immunopharmacol"},{"key":"6138_CR192","doi-asserted-by":"publisher","unstructured":"Kumar N, Mir PA, Bhutia GT, et al (2026) Reprogramming neuroinflammation: mitochondrial targets and immune checkpoint inhibitors in Alzheimer\u2019s disease. Mol Neurobiol 63. https:\/\/doi.org\/10.1007\/s12035-026-05983-w","DOI":"10.1007\/s12035-026-05983-w"},{"key":"6138_CR193","doi-asserted-by":"publisher","DOI":"10.3390\/biology9040086","author":"E Angelopoulou","year":"2020","unstructured":"Angelopoulou E, Paudel YN, Villa C et al (2020) Lymphocyte-activation gene 3 (LAG3) protein as a possible therapeutic target for Parkinson\u2019s disease: molecular mechanisms connecting neuroinflammation to \u03b1-synuclein spreading pathology. Biology (Basel). https:\/\/doi.org\/10.3390\/biology9040086","journal-title":"Biology (Basel)"},{"key":"6138_CR194","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.4049\/jimmunol.1800898","volume":"202","author":"D Kim","year":"2019","unstructured":"Kim D, Le HT, Nguyen QT et al (2019) Cutting edge: IL-27 attenuates autoimmune neuroinflammation via regulatory T cell\/Lag3-dependent but IL-10-independent mechanisms in vivo. J Immunol 202:1680\u20131685. https:\/\/doi.org\/10.4049\/jimmunol.1800898","journal-title":"J Immunol"},{"key":"6138_CR195","doi-asserted-by":"publisher","unstructured":"Ots HD, Tracz JA, Vinokuroff KE, Musto AE (2022) CD40-CD40L in neurological disease. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms23084115","DOI":"10.3390\/ijms23084115"},{"key":"6138_CR196","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.4103\/1673-5374.371357","volume":"18","author":"HY Wong","year":"2023","unstructured":"Wong HY, Chan ACY, Mak A, Schwarz H (2023) CD137L, a driver of harmful inflammation in the nervous system. Neural Regen Res 18:2387\u20132388. https:\/\/doi.org\/10.4103\/1673-5374.371357","journal-title":"Neural Regen Res"},{"key":"6138_CR197","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101125","author":"SS Siddiqui","year":"2019","unstructured":"Siddiqui SS, Matar R, Merheb M et al (2019) Siglecs in brain function and neurological disorders. Cells. https:\/\/doi.org\/10.3390\/cells8101125","journal-title":"Cells"},{"key":"6138_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00109-024-02504-x","volume":"103","author":"A Salminen","year":"2025","unstructured":"Salminen A (2025) The role of inhibitory immune checkpoint receptors in the pathogenesis of Alzheimer\u2019s disease. J Mol Med (Berl) 103:1\u201319. https:\/\/doi.org\/10.1007\/s00109-024-02504-x","journal-title":"J Mol Med (Berl)"},{"key":"6138_CR199","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/glia.22366","volume":"60","author":"M Hernang\u00f3mez","year":"2012","unstructured":"Hernang\u00f3mez M, Mestre L, Correa FG et al (2012) CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation. Glia 60:1437\u20131450. https:\/\/doi.org\/10.1002\/glia.22366","journal-title":"Glia"},{"key":"6138_CR200","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2021.103630","volume":"114","author":"K Lao","year":"2021","unstructured":"Lao K, Zhang R, Dai Y et al (2021) Identification of novel A\u03b2-LilrB2 inhibitors as potential therapeutic agents for Alzheimer\u2019s disease. Mol Cell Neurosci 114:103630. https:\/\/doi.org\/10.1016\/j.mcn.2021.103630","journal-title":"Mol Cell Neurosci"},{"key":"6138_CR201","doi-asserted-by":"publisher","unstructured":"Gheibihayat SM, Cabezas R, Nikiforov NG, et al (2021) CD47 in the brain and neurodegeneration: an update on the role in neuroinflammatory pathways. Molecules 26. https:\/\/doi.org\/10.3390\/molecules26133943","DOI":"10.3390\/molecules26133943"},{"key":"6138_CR202","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1089\/neu.2024.0047","volume":"41","author":"P Wang","year":"2024","unstructured":"Wang P, Yang X, Yang F et al (2024) Intravenous administration of anti-CD47 antibody augments hematoma clearance, mitigates acute neuropathology, and improves cognitive function in a rat model of penetrating traumatic brain injury. J Neurotrauma 41:2413\u20132427. https:\/\/doi.org\/10.1089\/neu.2024.0047","journal-title":"J Neurotrauma"},{"key":"6138_CR203","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.2174\/1381612820666140130202911","volume":"20","author":"M Hernang\u00f3mez","year":"2014","unstructured":"Hernang\u00f3mez M, Carrillo-Salinas FJ, Mecha M et al (2014) Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system. Curr Pharm Des 20:4707\u20134722. https:\/\/doi.org\/10.2174\/1381612820666140130202911","journal-title":"Curr Pharm Des"},{"key":"6138_CR204","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neuroscience.2018.10.030","volume":"405","author":"G Manich","year":"2019","unstructured":"Manich G, Recasens M, Valente T et al (2019) Role of the CD200-CD200R axis during homeostasis and neuroinflammation. Neuroscience 405:118\u2013136. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.10.030","journal-title":"Neuroscience"},{"key":"6138_CR205","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098230","author":"G Bivona","year":"2023","unstructured":"Bivona G, Iemmolo M, Ghersi G (2023) CX3CL1 pathway as a molecular target for treatment strategies in Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24098230","journal-title":"Int J Mol Sci"},{"key":"6138_CR206","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nm.4022","volume":"22","author":"K Baruch","year":"2016","unstructured":"Baruch K, Deczkowska A, Rosenzweig N et al (2016) PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer\u2019s disease. Nat Med 22:135\u2013137. https:\/\/doi.org\/10.1038\/nm.4022","journal-title":"Nat Med"},{"key":"6138_CR207","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1177\/1352458516662727","volume":"23","author":"SJ Khoury","year":"2017","unstructured":"Khoury SJ, Rochon J, Ding L et al (2017) ACCLAIM: a randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis. Mult Scler 23:686\u2013695. https:\/\/doi.org\/10.1177\/1352458516662727","journal-title":"Mult Scler"},{"key":"6138_CR208","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40982-8","volume":"14","author":"M Linnerbauer","year":"2023","unstructured":"Linnerbauer M, Beyer T, Nirschl L et al (2023) PD-L1 positive astrocytes attenuate inflammatory functions of PD-1 positive microglia in models of autoimmune neuroinflammation. Nat Commun 14:5555. https:\/\/doi.org\/10.1038\/s41467-023-40982-8","journal-title":"Nat Commun"},{"key":"6138_CR209","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1007\/s11357-023-01014-x","volume":"46","author":"SA DeVries","year":"2024","unstructured":"DeVries SA, Conner B, Dimovasili C et al (2024) Immune proteins C1q and CD47 may contribute to aberrant microglia-mediated synapse loss in the aging monkey brain that is associated with cognitive impairment. GeroScience 46:2503\u20132519. https:\/\/doi.org\/10.1007\/s11357-023-01014-x","journal-title":"GeroScience"},{"key":"6138_CR210","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/brain\/awq341","volume":"134","author":"D-S Yang","year":"2011","unstructured":"Yang D-S, Stavrides P, Mohan PS et al (2011) Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer\u2019s disease ameliorates amyloid pathologies and memory deficits. Brain 134:258\u2013277. https:\/\/doi.org\/10.1093\/brain\/awq341","journal-title":"Brain"},{"key":"6138_CR211","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.nbd.2018.03.007","volume":"114","author":"JR Paul","year":"2018","unstructured":"Paul JR, Munir HA, van Groen T, Gamble KL (2018) Behavioral and SCN neurophysiological disruption in the Tg-SwDI mouse model of Alzheimer\u2019s disease. Neurobiol Dis 114:194\u2013200. https:\/\/doi.org\/10.1016\/j.nbd.2018.03.007","journal-title":"Neurobiol Dis"},{"key":"6138_CR212","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1523\/JNEUROSCI.22-05-01858.2002","volume":"22","author":"MA Westerman","year":"2002","unstructured":"Westerman MA, Cooper-Blacketer D, Mariash A et al (2002) The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer\u2019s disease. J Neurosci Off J Soc Neurosci 22:1858\u20131867. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-05-01858.2002","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"6138_CR213","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/s0031-9384(01)00524-8","volume":"73","author":"C Janus","year":"2001","unstructured":"Janus C, Westaway D (2001) Transgenic mouse models of Alzheimer\u2019s disease. Physiol Behav 73:873\u2013886. https:\/\/doi.org\/10.1016\/s0031-9384(01)00524-8","journal-title":"Physiol Behav"},{"key":"6138_CR214","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/NEN.0b013e31818b48db","volume":"67","author":"Y Okura","year":"2008","unstructured":"Okura Y, Kohyama K, Park I-K, Matsumoto Y (2008) Nonviral DNA vaccination augments microglial phagocytosis of beta-amyloid deposits as a major clearance pathway in an Alzheimer disease mouse model. J Neuropathol Exp Neurol 67:1063\u20131071. https:\/\/doi.org\/10.1097\/NEN.0b013e31818b48db","journal-title":"J Neuropathol Exp Neurol"},{"key":"6138_CR215","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.bbadis.2009.10.013","volume":"1802","author":"C Schwab","year":"2010","unstructured":"Schwab C, Klegeris A, McGeer PL (2010) Inflammation in transgenic mouse models of neurodegenerative disorders. Biochim Biophys Acta 1802:889\u2013902. https:\/\/doi.org\/10.1016\/j.bbadis.2009.10.013","journal-title":"Biochim Biophys Acta"},{"key":"6138_CR216","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11481-007-9069-z","volume":"2","author":"DL Herber","year":"2007","unstructured":"Herber DL, Mercer M, Roth LM et al (2007) Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic mice. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol 2:222\u2013231. https:\/\/doi.org\/10.1007\/s11481-007-9069-z","journal-title":"J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol"},{"key":"6138_CR217","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/mt.2009.44","volume":"17","author":"T Kiyota","year":"2009","unstructured":"Kiyota T, Yamamoto M, Schroder B et al (2009) AAV1\/2-mediated CNS gene delivery of dominant-negative CCL2 mutant suppresses gliosis, beta-amyloidosis, and learning impairment of APP\/PS1 mice. Mol Ther 17:803\u2013809. https:\/\/doi.org\/10.1038\/mt.2009.44","journal-title":"Mol Ther"},{"key":"6138_CR218","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich DS, Lucchinetti CF, Calabresi PA (2018) Multiple sclerosis. N Engl J Med 378:169\u2013180. https:\/\/doi.org\/10.1056\/NEJMra1401483","journal-title":"N Engl J Med"},{"key":"6138_CR219","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","volume":"354","author":"CH Polman","year":"2006","unstructured":"Polman CH, O\u2019Connor PW, Havrdova E et al (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354:899\u2013910. https:\/\/doi.org\/10.1056\/NEJMoa044397","journal-title":"N Engl J Med"},{"key":"6138_CR220","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa1606468","volume":"376","author":"X Montalban","year":"2017","unstructured":"Montalban X, Hauser SL, Kappos L et al (2017) Ocrelizumab versus placebo in primary progressive multiple sclerosis. N Engl J Med 376:209\u2013220. https:\/\/doi.org\/10.1056\/NEJMoa1606468","journal-title":"N Engl J Med"},{"key":"6138_CR221","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/brain\/awq386","volume":"134","author":"RA Linker","year":"2011","unstructured":"Linker RA, Lee D-H, Ryan S et al (2011) Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 134:678\u2013692. https:\/\/doi.org\/10.1093\/brain\/awq386","journal-title":"Brain"},{"key":"6138_CR222","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1517\/14656566.2013.754012","volume":"14","author":"G Comi","year":"2013","unstructured":"Comi G, Hartung H-P, Kurukulasuriya NC et al (2013) Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis. Expert Opin Pharmacother 14:123\u2013136. https:\/\/doi.org\/10.1517\/14656566.2013.754012","journal-title":"Expert Opin Pharmacother"},{"key":"6138_CR223","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1212\/WNL.0000000000000317","volume":"82","author":"M Araki","year":"2014","unstructured":"Araki M, Matsuoka T, Miyamoto K et al (2014) Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. Neurology 82:1302\u20131306. https:\/\/doi.org\/10.1212\/WNL.0000000000000317","journal-title":"Neurology"},{"key":"6138_CR224","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1056\/NEJMoa1901747","volume":"381","author":"T Yamamura","year":"2019","unstructured":"Yamamura T, Kleiter I, Fujihara K et al (2019) Trial of satralizumab in neuromyelitis optica spectrum disorder. N Engl J Med 381:2114\u20132124. https:\/\/doi.org\/10.1056\/NEJMoa1901747","journal-title":"N Engl J Med"},{"key":"6138_CR225","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00415-016-8128-x","volume":"263","author":"E Havrdov\u00e1","year":"2016","unstructured":"Havrdov\u00e1 E, Belova A, Goloborodko A et al (2016) Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study. J Neurol 263:1287\u20131295. https:\/\/doi.org\/10.1007\/s00415-016-8128-x","journal-title":"J Neurol"},{"key":"6138_CR226","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102647","volume":"19","author":"T Moser","year":"2020","unstructured":"Moser T, Akg\u00fcn K, Proschmann U et al (2020) The role of TH17 cells in multiple sclerosis: therapeutic implications. Autoimmun Rev 19:102647. https:\/\/doi.org\/10.1016\/j.autrev.2020.102647","journal-title":"Autoimmun Rev"},{"key":"6138_CR227","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11910-017-0742-1","volume":"17","author":"E Kemanetzoglou","year":"2017","unstructured":"Kemanetzoglou E, Andreadou E (2017) CNS demyelination with TNF-\u03b1 blockers. Curr Neurol Neurosci Rep 17:36. https:\/\/doi.org\/10.1007\/s11910-017-0742-1","journal-title":"Curr Neurol Neurosci Rep"},{"key":"6138_CR228","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102290","author":"D Fresegna","year":"2020","unstructured":"Fresegna D, Bullitta S, Musella A et al (2020) Re-examining the role of TNF in MS pathogenesis and therapy. Cells. https:\/\/doi.org\/10.3390\/cells9102290","journal-title":"Cells"},{"key":"6138_CR229","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/rheumatology\/kev403","volume":"55","author":"M Bonelli","year":"2016","unstructured":"Bonelli M, G\u00f6schl L, Bl\u00fcml S et al (2016) Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis. Rheumatology (Oxford) 55:710\u2013720. https:\/\/doi.org\/10.1093\/rheumatology\/kev403","journal-title":"Rheumatology (Oxford)"},{"key":"6138_CR230","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/S0140-6736(18)32167-6","volume":"392","author":"RF van Vollenhoven","year":"2018","unstructured":"van Vollenhoven RF, Hahn BH, Tsokos GC et al (2018) Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study. Lancet 392:1330\u20131339. https:\/\/doi.org\/10.1016\/S0140-6736(18)32167-6","journal-title":"Lancet"},{"key":"6138_CR231","doi-asserted-by":"publisher","first-page":"28539","DOI":"10.18632\/oncotarget.5164","volume":"6","author":"W Guo","year":"2015","unstructured":"Guo W, Wang C, Wang X et al (2015) A novel human truncated IL12r\u03b21-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation. Oncotarget 6:28539\u201328555. https:\/\/doi.org\/10.18632\/oncotarget.5164","journal-title":"Oncotarget"},{"key":"6138_CR232","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41573-019-0041-4","volume":"18","author":"LMR Ferreira","year":"2019","unstructured":"Ferreira LMR, Muller YD, Bluestone JA, Tang Q (2019) Next-generation regulatory T cell therapy. Nat Rev Drug Discov 18:749\u2013769. https:\/\/doi.org\/10.1038\/s41573-019-0041-4","journal-title":"Nat Rev Drug Discov"},{"key":"6138_CR233","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000465","volume":"5","author":"JR Thonhoff","year":"2018","unstructured":"Thonhoff JR, Beers DR, Zhao W et al (2018) Expanded autologous regulatory T-lymphocyte infusions in ALS: a phase I, first-in-human study. Neurol Neuroimmunol Neuroinflamm 5:e465. https:\/\/doi.org\/10.1212\/NXI.0000000000000465","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"6138_CR234","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/brain\/awv408","volume":"139","author":"C Dansokho","year":"2016","unstructured":"Dansokho C, Ait Ahmed D, Aid S et al (2016) Regulatory T cells delay disease progression in Alzheimer-like pathology. Brain 139:1237\u20131251. https:\/\/doi.org\/10.1093\/brain\/awv408","journal-title":"Brain"},{"key":"6138_CR235","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nri3823","volume":"15","author":"D Klatzmann","year":"2015","unstructured":"Klatzmann D, Abbas AK (2015) The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases. Nat Rev Immunol 15:283\u2013294. https:\/\/doi.org\/10.1038\/nri3823","journal-title":"Nat Rev Immunol"},{"key":"6138_CR236","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neuroscience.2019.06.006","volume":"414","author":"MJ Churchill","year":"2019","unstructured":"Churchill MJ, Cantu MA, Kasanga EA et al (2019) Glatiramer acetate reverses motor dysfunction and the decrease in tyrosine hydroxylase levels in a mouse model of Parkinson\u2019s disease. Neuroscience 414:8\u201327. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.06.006","journal-title":"Neuroscience"},{"key":"6138_CR237","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.brainresbull.2023.03.005","volume":"196","author":"Y-R Wang","year":"2023","unstructured":"Wang Y-R, Cui W-Q, Wu H-Y et al (2023) The role of T cells in acute ischemic stroke. Brain Res Bull 196:20\u201333. https:\/\/doi.org\/10.1016\/j.brainresbull.2023.03.005","journal-title":"Brain Res Bull"},{"key":"6138_CR238","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030309","volume":"9","author":"B Willekens","year":"2019","unstructured":"Willekens B, Presas-Rodr\u00edguez S, Mansilla MJ et al (2019) Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration. BMJ Open 9:e030309. https:\/\/doi.org\/10.1136\/bmjopen-2019-030309","journal-title":"BMJ Open"},{"key":"6138_CR239","doi-asserted-by":"crossref","unstructured":"Moorman CD, Sohn SJ, Phee H (2021) Emerging therapeutics for immune tolerance: tolerogenic vaccines, T cell therapy, and IL-2 therapy. Front Immunol Volume 12\u20132021","DOI":"10.3389\/fimmu.2021.657768"},{"key":"6138_CR240","doi-asserted-by":"publisher","unstructured":"Bhutia GT, De AK, Bera T (2022) Validation, stability studies, and simultaneous estimation of co-encapsulated curcumin, epigallocatechin gallate nanoformulation by RP-HPLC method. Int J Appl Pharm 14:186\u2013195. https:\/\/doi.org\/10.22159\/ijap.2022v14i6.45818","DOI":"10.22159\/ijap.2022v14i6.45818"},{"key":"6138_CR241","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.132369","volume":"271","author":"GT Bhutia","year":"2024","unstructured":"Bhutia GT, De AK, Bhowmik M, Bera T (2024) Shellac and locust bean gum coacervated curcumin, epigallocatechin gallate nanoparticle ameliorates diabetic nephropathy in a streptozotocin-induced mouse model. Int J Biol Macromol 271:132369. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.132369","journal-title":"Int J Biol Macromol"},{"key":"6138_CR242","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2025.100742","volume":"5","author":"GT Bhutia","year":"2025","unstructured":"Bhutia GT, De AK, Bhowmik M et al (2025) Evaluation of the antidiabetic and antinephritic effects of Pueraria tuberosa and Pterocarpus santalinus extracts co-encapsulated in nanostructured lipid carriers in streptozotocin-induced mouse model. Phytomedicine Plus 5:100742. https:\/\/doi.org\/10.1016\/j.phyplu.2025.100742","journal-title":"Phytomedicine Plus"},{"key":"6138_CR243","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1021\/acs.molpharmaceut.2c00277","volume":"19","author":"I Triantafyllakou","year":"2022","unstructured":"Triantafyllakou I, Clemente N, Khetavat RK et al (2022) Development of PLGA nanoparticles with a glycosylated myelin oligodendrocyte glycoprotein epitope (MOG(35\u201355)) against experimental autoimmune encephalomyelitis (EAE). Mol Pharm 19:3795\u20133805. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00277","journal-title":"Mol Pharm"},{"key":"6138_CR244","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.889291","volume":"10","author":"H Li","year":"2022","unstructured":"Li H, Yang Y-G, Sun T (2022) Nanoparticle-based drug delivery systems for induction of tolerance and treatment of autoimmune diseases. Front Bioeng Biotechnol 10:889291. https:\/\/doi.org\/10.3389\/fbioe.2022.889291","journal-title":"Front Bioeng Biotechnol"},{"key":"6138_CR245","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/nbt.2434","volume":"30","author":"DR Getts","year":"2012","unstructured":"Getts DR, Martin AJ, McCarthy DP et al (2012) Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nat Biotechnol 30:1217\u20131224. https:\/\/doi.org\/10.1038\/nbt.2434","journal-title":"Nat Biotechnol"},{"key":"6138_CR246","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2026.177692","volume":"542","author":"L Xiang","year":"2026","unstructured":"Xiang L, Zhang J, Wu Y et al (2026) CHBP-loaded mesoporous polydopamine nanoparticles attenuate neuroinflammation and reprogram microglia-neuron crosstalk for spinal cord injury repair. Chem Eng J 542:177692. https:\/\/doi.org\/10.1016\/j.cej.2026.177692","journal-title":"Chem Eng J"},{"key":"6138_CR247","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","volume":"64","author":"S Gilman","year":"2005","unstructured":"Gilman S, Koller M, Black RS et al (2005) Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology 64:1553\u20131562. https:\/\/doi.org\/10.1212\/01.WNL.0000159740.16984.3C","journal-title":"Neurology"},{"key":"6138_CR248","doi-asserted-by":"publisher","DOI":"10.1042\/AN20120066","author":"V Sanchez-Guajardo","year":"2013","unstructured":"Sanchez-Guajardo V, Barnum CJ, Tansey MG, Romero-Ramos M (2013) Neuroimmunological processes in Parkinson\u2019s disease and their relation to \u03b1-synuclein: microglia as the referee between neuronal processes and peripheral immunity. ASN Neuro. https:\/\/doi.org\/10.1042\/AN20120066","journal-title":"ASN Neuro"},{"key":"6138_CR249","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1474-4422(20)30136-8","volume":"19","author":"D Volc","year":"2020","unstructured":"Volc D, Poewe W, Kutzelnigg A et al (2020) Safety and immunogenicity of the \u03b1-synuclein active immunotherapeutic PD01A in patients with Parkinson\u2019s disease: a randomised, single-blinded, phase 1 trial. Lancet Neurol 19:591\u2013600. https:\/\/doi.org\/10.1016\/S1474-4422(20)30136-8","journal-title":"Lancet Neurol"},{"key":"6138_CR250","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.624685","volume":"12","author":"J Derdelinckx","year":"2021","unstructured":"Derdelinckx J, Cras P, Berneman ZN, Cools N (2021) Antigen-specific treatment modalities in MS: the past, the present, and the future. Front Immunol 12:624685. https:\/\/doi.org\/10.3389\/fimmu.2021.624685","journal-title":"Front Immunol"},{"key":"6138_CR251","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.640935","volume":"12","author":"A Lutterotti","year":"2021","unstructured":"Lutterotti A, Hayward-Koennecke H, Sospedra M, Martin R (2021) Antigen-specific immune tolerance in multiple sclerosis-promising approaches and how to bring them to patients. Front Immunol 12:640935. https:\/\/doi.org\/10.3389\/fimmu.2021.640935","journal-title":"Front Immunol"},{"key":"6138_CR252","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41423-024-01148-8","volume":"21","author":"S Ma","year":"2024","unstructured":"Ma S, Ming Y, Wu J, Cui G (2024) Cellular metabolism regulates the differentiation and function of T-cell subsets. Cell Mol Immunol 21:419\u2013435. https:\/\/doi.org\/10.1038\/s41423-024-01148-8","journal-title":"Cell Mol Immunol"},{"key":"6138_CR253","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1690141","volume":"17","author":"Y Ma","year":"2026","unstructured":"Ma Y, Zhang Q, Ding Z (2026) Metabolic checkpoints in the regulation of Th17 cells: implications for uveitis pathogenesis and therapy. Front Immunol 17:1690141. https:\/\/doi.org\/10.3389\/fimmu.2026.1690141","journal-title":"Front Immunol"},{"key":"6138_CR254","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-026-01282-6","volume":"19","author":"PA Barnie","year":"2026","unstructured":"Barnie PA, Pomeyie K, Amoani B et al (2026) CD4+T cell metabolic reprogramming as therapeutic targets in neurodegenerative diseases. Mol Brain 19:10.1186\/s13041-026-01282-6","journal-title":"Mol Brain"},{"key":"6138_CR255","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.98514","volume":"17","author":"J Zerdka","year":"2025","unstructured":"Zerdka J, Brasse P, Piszka M et al (2025) The mechanistic target of rapamycin (mTOR) pathway as a target of anti-aging therapies: the role of rapamycin and its analogs in the regulation of cellular processes and their impact on longevity. Cureus 17:e98514. https:\/\/doi.org\/10.7759\/cureus.98514","journal-title":"Cureus"},{"key":"6138_CR256","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM (2017) mTOR signaling in growth, metabolism, and disease. Cell 168:960\u2013976. https:\/\/doi.org\/10.1016\/j.cell.2017.02.004","journal-title":"Cell"},{"key":"6138_CR257","first-page":"2393","volume":"11","author":"W Duan","year":"2019","unstructured":"Duan W, Ding Y, Yu X et al (2019) Metformin mitigates autoimmune insulitis by inhibiting Th1 and Th17 responses while promoting Treg production. Am J Transl Res 11:2393\u20132402","journal-title":"Am J Transl Res"},{"key":"6138_CR258","doi-asserted-by":"publisher","first-page":"C873","DOI":"10.1152\/ajpcell.00604.2020","volume":"320","author":"LP Bharath","year":"2021","unstructured":"Bharath LP, Nikolajczyk BS (2021) The intersection of metformin and inflammation. Am J Physiol Cell Physiol 320:C873\u2013C879. https:\/\/doi.org\/10.1152\/ajpcell.00604.2020","journal-title":"Am J Physiol Cell Physiol"},{"key":"6138_CR259","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fimmu.2017.00311","volume":"8","author":"KJ Binger","year":"2017","unstructured":"Binger KJ, C\u00f4rte-Real BF, Kleinewietfeld M (2017) Immunometabolic regulation of interleukin-17-producing T helper cells: uncoupling new targets for autoimmunity. Front Immunol 8:311. https:\/\/doi.org\/10.3389\/fimmu.2017.00311","journal-title":"Front Immunol"},{"key":"6138_CR260","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2019.103409","volume":"101","author":"ML Young","year":"2019","unstructured":"Young ML, Franklin JL (2019) The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice. Mol Cell Neurosci 101:103409. https:\/\/doi.org\/10.1016\/j.mcn.2019.103409","journal-title":"Mol Cell Neurosci"},{"key":"6138_CR261","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2026.114988","volume":"29","author":"DN Stein","year":"2026","unstructured":"Stein DN, Gendelman HE (2026) CAR Treg therapies for neurodegenerative diseases. iScience 29:114988. https:\/\/doi.org\/10.1016\/j.isci.2026.114988","journal-title":"iScience"},{"key":"6138_CR262","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12974-024-03262-w","volume":"21","author":"J Frikeche","year":"2024","unstructured":"Frikeche J, David M, Mouska X et al (2024) MOG-specific CAR Tregs: a novel approach to treat multiple sclerosis. J Neuroinflammation 21:268. https:\/\/doi.org\/10.1186\/s12974-024-03262-w","journal-title":"J Neuroinflammation"},{"key":"6138_CR263","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020287","author":"M Arjomandnejad","year":"2022","unstructured":"Arjomandnejad M, Kopec AL, Keeler AM (2022) CAR-T regulatory (CAR-Treg) cells: engineering and applications. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10020287","journal-title":"Biomedicines"},{"key":"6138_CR264","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-026-00627-z","author":"J Alshorman","year":"2026","unstructured":"Alshorman J, Mehran MJ, Miyanda Tembo K et al (2026) Applications of genome editing technologies in the treatment of human diseases. Gene Ther. https:\/\/doi.org\/10.1038\/s41434-026-00627-z","journal-title":"Gene Ther"},{"key":"6138_CR265","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.655122","volume":"12","author":"L Van Zeebroeck","year":"2021","unstructured":"Van Zeebroeck L, Arroyo Hornero R, C\u00f4rte-Real BF et al (2021) Fast and efficient genome editing of human FOXP3(+) regulatory T cells. Front Immunol 12:655122. https:\/\/doi.org\/10.3389\/fimmu.2021.655122","journal-title":"Front Immunol"},{"key":"6138_CR266","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.1016\/j.ymthe.2026.03.017","volume":"34","author":"Y Honaker","year":"2026","unstructured":"Honaker Y, Dahl NP, Singh S et al (2026) Preclinical efficacy and safety assessment of engineered regulatory T cells for treatment of IPEX and other autoimmune disorders. Mol Ther 34:4035\u20134053. https:\/\/doi.org\/10.1016\/j.ymthe.2026.03.017","journal-title":"Mol Ther"},{"key":"6138_CR267","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031689","author":"A Rezalotfi","year":"2022","unstructured":"Rezalotfi A, Fritz L, F\u00f6rster R, Bo\u0161njak B (2022) Challenges of CRISPR-based gene editing in primary T cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23031689","journal-title":"Int J Mol Sci"},{"key":"6138_CR268","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911206","author":"C Lin","year":"2022","unstructured":"Lin C, Guo J, Jia R (2022) Roles of regulatory T cell-derived extracellular vesicles in human diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms231911206","journal-title":"Int J Mol Sci"},{"key":"6138_CR269","doi-asserted-by":"publisher","DOI":"10.34172\/bi.30880","volume":"15","author":"IA Ganeeva","year":"2025","unstructured":"Ganeeva IA, Gilyazova EM, Khannanov AA et al (2025) Allogeneic Treg-derived artificial vesicles: a promising therapeutic modality for multiple sclerosis. Bioimpacts 15:30880. https:\/\/doi.org\/10.34172\/bi.30880","journal-title":"Bioimpacts"},{"key":"6138_CR270","doi-asserted-by":"publisher","first-page":"5044","DOI":"10.7150\/thno.131621","volume":"16","author":"J Zhang","year":"2026","unstructured":"Zhang J, Pan Y, She P, Rao L (2026) From bench to bedside: the promise and roadblocks of extracellular vesicle therapeutics. Theranostics 16:5044\u20135064. https:\/\/doi.org\/10.7150\/thno.131621","journal-title":"Theranostics"},{"key":"6138_CR271","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20786-w","volume":"12","author":"Y Tian","year":"2021","unstructured":"Tian Y, Han C, Wei Z et al (2021) SOX-5 activates a novel ROR\u03b3t enhancer to facilitate experimental autoimmune encephalomyelitis by promoting Th17 cell differentiation. Nat Commun 12:481. https:\/\/doi.org\/10.1038\/s41467-020-20786-w","journal-title":"Nat Commun"},{"key":"6138_CR272","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12929-025-01120-2","volume":"32","author":"Q Zeng","year":"2025","unstructured":"Zeng Q, Guo H, Tang N et al (2025) K27-linked ROR\u03b3t ubiquitination by Nedd4 potentiates Th17-mediated autoimmunity. J Biomed Sci 32:26. https:\/\/doi.org\/10.1186\/s12929-025-01120-2","journal-title":"J Biomed Sci"},{"key":"6138_CR273","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jconrel.2023.03.009","volume":"356","author":"L Nieland","year":"2023","unstructured":"Nieland L, Mahjoum S, Grandell E et al (2023) Engineered EVs designed to target diseases of the CNS. J Control Release 356:493\u2013506. https:\/\/doi.org\/10.1016\/j.jconrel.2023.03.009","journal-title":"J Control Release"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06138-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06138-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06138-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:47:40Z","timestamp":1787042860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06138-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":273,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6138"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06138-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"843"}}